Document is current

Any future updates will be listed below

Multiples Myelom: Anti-CD38-Antikörper bewährt sich in Primärtherapie

Crossref DOI link: https://doi.org/10.1007/s15015-021-3762-2

Published Online: 2022-02-02

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark